Filter Results:
(1,329)
Show Results For
- All HBS Web
(1,329)
- People (1)
- News (333)
- Research (819)
- Events (1)
- Multimedia (8)
- Faculty Publications (593)
Show Results For
- All HBS Web
(1,329)
- People (1)
- News (333)
- Research (819)
- Events (1)
- Multimedia (8)
- Faculty Publications (593)
- Web
Blog | Social Enterprise | Harvard Business School
Impact Measurement Inclusive Finance International Development K-12 Education Leadership Fellows Leadership in Challenging Times MBA Programs Microfinance Non Profit Management Nonprofit Supportive Services Public Sector Public-Private... View Details
- 10 Sep 2014
- Blog Post
A Summer Reflection
allowing them to take on some very exciting projects. One HBS intern was on the clinics team, seeking to roll out basic primary care health services in stores- this has been in the news a bit lately as it ramps up. I sat next to the Made... View Details
- 01 Dec 2009
- News
Seven Honored with Alumni Achievement Award
On October 19, the School conferred its highest honor, the Alumni Achievement Award, on seven distinguished individuals. Since 1968, the School has selected outstanding men and women for the award, recognizing their accomplishments in the public and the private... View Details
Jon Staff
Point Foundation mentor, and a Harvard Business School Entrepreneur-in-Residence. He earned his AB and MBA from Harvard University and lives in Brooklyn and Boston with his husband, Michael. Jon can be particularly helpful with: - Brick-and-mortar businesses -... View Details
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Health Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- May 4, 2023
- Article
Falling Insulin Prices—What Just Happened?
By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details
Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry
Dafny, Leemore S. "Falling Insulin Prices—What Just Happened?" New England Journal of Medicine 388, no. 18 (May 4, 2023): 1636–1639.
- Article
Strategic Assets, Interdependence and Technological Change: An Empirical Investigation of Complementarity in Pharmaceutical Drug Discovery
By: S. Thomke and W. Kuemmerle
Keywords: Strategy; Assets; Information Technology; Change; Information; Health; Pharmaceutical Industry
Thomke, S., and W. Kuemmerle. "Strategic Assets, Interdependence and Technological Change: An Empirical Investigation of Complementarity in Pharmaceutical Drug Discovery." Academy of Management Proceedings and Membership Directory (2000).
- Fast Answer
Challenges and Opportunities in the Restaurant Industry
Resources Company Analysis and Financing Company profiles on project sponsors Financial fundamentals for valuation Executive bios Size of organization, i.e., number of employees, revenue View Details
- October 2024
- Article
Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates
By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to negotiate rebates and lead to higher spending. We estimated the association between protected-class status, US-level estimated... View Details
Keywords: Insurance; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States
Kakani, Pragya, Michael Anne Kyle, Amitabh Chandra, and Luca Maini. "Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates." Health Affairs 43, no. 10 (October 2024): 1420–1427.
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that... View Details
Keywords: Policy; Government Legislation; Health Care and Treatment; Negotiation; Price; Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- June 9, 2023
- Article
A Radical Treatment for Insulin Pricing
By: Leemore S. Dafny
In 2021, the Food and Drug Administration (FDA) approved the first interchangeable biosimilar for long-acting insulin, which many hoped would be substantially cheaper than the reference branded product. I explain why prices have barely changed, and argue that a... View Details
Keywords: Biosimilars; Rebates; Pharmaceuticals; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; United States
Dafny, Leemore S. "A Radical Treatment for Insulin Pricing." New England Journal of Medicine 386, no. 23 (June 9, 2023): 2157–2159.
- April 2018 (Revised September 2018)
- Case
Impact Investing for Cancer
By: Richard G. Hamermesh and Matthew G. Preble
It is early 2018, and Emily Park, managing director of impact for the Abreu Family Office, is meeting the next day with Tomás and Maria Abreu to discuss the various ways in which the Abreus can allocate a planned $100 million to make a meaningful difference in cancer... View Details
Keywords: Impact Investing; Investment; Health Disorders; Philanthropy and Charitable Giving; Decision Choices and Conditions
Hamermesh, Richard G., and Matthew G. Preble. "Impact Investing for Cancer." Harvard Business School Case 818-068, April 2018. (Revised September 2018.)
- 18 Feb 2010
- News
A Mission to Improve Patients' Lives
- 15 Dec 2015
- News
The Year in Ideas 2015
help. Founded in 2012 in Washington, DC, by Dan Mindus (MBA 2008), the group of more than 90 has become one of the most active tech investors in that city, providing financing and networking opportunities to young companies, such as... View Details
- 01 Jun 2000
- News
VC Luminary John Doerr: Education Reform Critical to Success of New Economy
Industrial Revolution. The wiring of the world with fiber-optic cable, he said, combined with the launching of a new generation of satellites, presents the potential for revolutions in communications and health care, as well as in... View Details
- 01 Dec 2003
- News
Alumni Bookshelf
Health Care Organizations by David W. Young (DBA ’77) (Jossey-Bass) Young, a member of the faculty at Boston University’s School of Management who will teach next semester at IESE Business School in Barcelona, specializes in management... View Details
- January 2011
- Teaching Note
Ganeden Biotech, Inc. (TN)
By: Robert C. Pozen, Dale Alan Winger and Matthew Kenneth Ahlers
Teaching Note for 310073. View Details
- Web
Staff Directory | Baker Library
Curriculum & Learning Services Colette Ciregna Director Administration & Finance Areas of Expertise: Finance, Accounting, Staff relations, HR, Operations, French Patrick Clapp Information Research Specialist Baker Research & Data Services... View Details
- Article
Unhealthy Consumerism: The Challenge of Trading Off Price and Quality in Healthcare
By: Kate Barasz and Peter A. Ubel
Over the last decade, healthcare in many parts of the world has shifted toward a more patient-centric, consumeristic model, marked by an emphasis on choice and a proliferation of typical consumer-facing information (e.g., price and quality data). However, while the... View Details
Keywords: Medical Decision-making; Choice; Health Care and Treatment; Quality; Price; Consumer Behavior; Decision Making
Barasz, Kate, and Peter A. Ubel. "Unhealthy Consumerism: The Challenge of Trading Off Price and Quality in Healthcare." Behavioural Public Policy 2, no. 1 (May 2018): 41–55.
- August 2007 (Revised November 2008)
- Case
Biocon: Launching a New Cancer Drug in India
By: Sunil Gupta and Das Narayandas
Kiran Majumdar-Shaw, the CEO of Biocon has to make product launch timing, pricing, channel, and communications mix decisions relating to the launch of BioMAb, a new cancer drug in India. View Details
Keywords: Price; Health Care and Treatment; Marketing Strategy; Product Launch; Planning; Biotechnology Industry; Pharmaceutical Industry; India
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India." Harvard Business School Case 508-026, August 2007. (Revised November 2008.)